Patents by Inventor Yves Deshaies

Yves Deshaies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating and/or suppressing insulin resistance
    Patent number: 8609695
    Abstract: Novel methods for the medical treatment and/or prevention of obesity, abdominal fat, and insulin resistance in susceptible warm-blooded animals including humans involves the administration of selective estrogen receptor modulators (SERMs). A combination of a SERM with an amount of estrogen or a sex steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-ene-3b,17b-diol and compounds converted in vivo to one of the foregoing precursors or estrogen is also disclosed.
    Type: Grant
    Filed: March 10, 2003
    Date of Patent: December 17, 2013
    Assignee: Endorecherche, Inc.
    Inventors: Fernand Labrie, Yves Deshaies, Denis Richard, Celine Martel, Andre Marette
  • Methods of treating and/or suppressing weight gain
    Patent number: 6710059
    Abstract: Novel methods for the medical treatment and/or prevention of obesity, abdominal fat, and insulin resistance in susceptible warm-blooded animals including humans involves the administration of selective estrogen receptor modulators (SERMs). A combination of a SERM with an amount of estrogen or a sex steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-ene-3b,17b-diol and compounds converted in vivo to one of the foregoing precursors or estrogen is also disclosed.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: March 23, 2004
    Assignee: Endorecherche, Inc.
    Inventors: Fernand Labrie, Yves Deshaies, Denis Richard, Celine Martel, Andre Marette
  • Methods of treating and/or suppressing insulin resistance
    Publication number: 20040034000
    Abstract: Novel methods for the medical treatment and/or prevention of obesity, abdominal fat, and insulin resistance in susceptible warm-blooded animals including humans involves the administration of selective estrogen receptor modulators (SERMs). A combination of a SERM with an amount of estrogen or a sex steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androst-5-ene-3b,17b-diol and compounds converted in vivo to one of the foregoing precursors or estrogen is also disclosed.
    Type: Application
    Filed: March 10, 2003
    Publication date: February 19, 2004
    Applicant: Endorecherche, Inc.
    Inventors: Fernand Labrie, Yves Deshaies, Denis Richard, Celine Martel, Andre Marette